Phaseline

Companies › Palvella Therapeutics

Palvella Therapeutics: clinical trials, targets and expected readouts

2 active drug programs in 4 registered trials: 2 Phase 3, 2 Phase 2; Other; next expected readout Aug 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Sirolimus (PTX-022)
FK506-binding protein 1A inhibitor
FKBP1APhase 3Pachyonychia Congenita; Cutaneous Venous Malformations; AngiokeratomasAug 2027
QTORIN 3.9% Rapamycin Anhydrous Gel
mTOR inhibitor
MTORPhase 3Microcystic Lymphatic Malformation–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05643872Sirolimus (PTX-022)Phase 3Pachyonychia CongenitaOtherOct 2023
NCT06653842Sirolimus (PTX-022)Phase 2Cutaneous Venous MalformationsOtherNov 2025
NCT06239480QTORIN 3.9% Rapamycin Anhydrous GelPhase 3Microcystic Lymphatic MalformationOtherJan 2026
NCT07552077Sirolimus (PTX-022)Phase 2AngiokeratomasOtherAug 2027

From the company's SEC filings

Cash and short-term investments of $237m on 2026-09-30; operating cash outflow about $51m a year; runway about 56 months at that burn, to May 2031; 1 of 1 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Regulatory dates the company has stated

Agreements filed with the SEC (item 1.01), last two years

Targets

FKBP1A (1) MTOR (1)

Companies with the same targets

Restorbio Eisai CSPC ZhongQi Pharmaceutical Technology Novartis Rapamycin Holdings AgelessRx Novaliq Jiangsu Simcere Pharmaceutical Aadi Bioscience Eyestem Research

Companies built like this

Sound Pharmaceuticals Intuitive Surgical Axsome Therapeutics Huons Biopharma Neuren Pharmaceuticals

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.